You Position: Home > Paper

The efficacy of combivent and chymotrypsin inhalants in the patients with chronic obstructive pulmonary disease

( views:421, downloads:61 )
Author:
No author available
Journal Title:
China Medicine
Issue:
4
DOI:
10.3760/cma.j.issn.1673-4777.2012.04.005
Key Word:
慢性阻塞性肺疾病;复方异丙托溴铵气雾剂;糜蛋白酶;雾化吸入治疗;Chronic obstructive pulmonary disease;Combivent;Alpha-chymotrypsin;Inhalation therapy

Abstract: Objective To investigate the effect of combivent and alpha-chymotrypsin inhalants on the improvement of lung function in patients with chronic obstructive pulmonary disease (COPD).Methods One hundred and fifty patients with COPD were ranked in the order of COPD severity and a comprehensive evaluation of age,smoking status and other complications which may have effects on lung function.According to the rank of the patients,they were classified into three groups (combivent,alpha-chymotrypsin and control groups) according to remainder after their ranking numbers were divided by three.Each patient was given treatment two times ( one in the morning and one in the afternoon) for 5 consecutive days.Lung function and blood gas were detected before first spray atomization and after last treatment.The parameters such as forced vital capacity (FVC),Forced expiratory volume in one second (FEV1%),arterial oxygen pressure (PaO2 ),arterial carbon dioxide partial pressure ( PaCO2 ),arterial oxygen saturation (SaO2 ) were compared.Results In the combivent group,the parameters before and after treatment were:FVC[(69 ±17)%,(74±15)%,t =-4.223,P<0.O1],FEV1% [(68±21)%,(71 ±20)%,t=-2.777,P=0.008],PaO2[(74±7),(76±6)mmHg,t=-11.201,P<0.01],PaCO2[(40±3),(39±2)mm Hg,t=3.888,P<0.01],SaO2[(94.4±1.7)%,(94.9±1.1)%,t=-4.452,P <0.01 ].In the alpha-chymotrypsin group,the parameters before and after treatment were:FVC[ (66 ±13)%,(70±14)%,t=-32.375,P=0.022],FEV1% [(63±13)%,(66±15)%,t=-2.229,P=0.030],PaO2[(72±8),(76±6)mmHg,t=-18.763,P<0.01],PaCO2[(40±3),(38±2)mmHg,t=6.137,P<0.01],SaO2[(94.0±1.8)%,(95.0±1.3)%,t=-9.339,P<0.001.Conclusion Combivent and alpha-chymotrypsin inhalants are both effective to improve the lung function of patients with COPD.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn